Protagonist Therapeutics
PTGX
PTGX
127 hedge funds and large institutions have $1.15B invested in Protagonist Therapeutics in 2021 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 43 increasing their positions, 40 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
-1
Holders Change %
-0.78%
% of All Funds
2.24%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.09%
New
25
Increased
43
Reduced
40
Closed
26
Calls
$810K
Puts
$1.12M
Net Calls
-$313K
Net Calls Change
+$374K
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.2M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$8.14M |
| 3 |
PA
Perceptive Advisors
New York
|
-$4.1M |
| 4 |
RI
RTW Investments
New York
|
-$3.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.69M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
151
Simplex Trading
Chicago,
Illinois
| – | -$19K | -944 | Closed |
|
|
FQ
152
First Quadrant
Glendale,
California
| – | -$8K | -410 | Closed |
|
|
SPIA
153
Steward Partners Investment Advisory
New York
| – | -$1K | -40 | Closed |
|